Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease

European Heart Journal

Volumn 24, Issue 18, 2003, Pages 1668-1671

  Ye, Shu ^a   Gale, Catharine R ^b   Martyn, Christopher N ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Coronary heart disease; Epidemiology; Gene expression; Matrix metalloproteinase 1; Matrix metalloproteinase 3; Polymorphism

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; INTERSTITIAL COLLAGENASE; STROMELYSIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME DEGRADATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOME; GENOTYPE; HOMOZYGOSITY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0141426743     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(03)00385-3     Document Type: Article

References (13)

1. Galis ZS, Sukhova GK, Lark MW et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-503.
2. Lemaitre V, O'Byrne TK, Borczuk AC et al. ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest 2001;107:1227-34.
3. Rutter JL, Mitchell TI, Buttice G et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998;58:5321-5.
4. Kanamori Y, Matsushima M, Minaguchi T et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 1999;59:4225-7.
5. Ye S, Eriksson P, Hamsten A et al. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996;271:13055-60.
6. Humphries SE, Luong LA, Talmud PJ et al. The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial. Atherosclerosis 1998;139:49-56.
7. Dunleavey L, Beyzade S, Ye S. Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer. Matrix Biol 2000;19:175-7.
8. Dunleavy L, Beyzade S, Ye S. Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism. Atherosclerosis 2000;151:587-9.
9. Ghilardi G, Biondi ML, DeMonti M et al. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with cartoid artery stenosis. Stroke 2002;33:2408-12.
10. Wesley RB II, Meng X, Godin D et al. Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro. Arterioscler Thromb Vasc Biol 1998;18:432-40.
11. Rocnik EF, Chan BMC, Pickering G. Evidence for a role of collagen synthesis in arterial smooth muscle cell migration. J Clin Invest 1998;101:1889-98.
12. Attie AD. Atherosclerosis modified. Circ Res 2001;89:102-4.
13. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002;90:251-62.